Stockholders' Deficit - Schedule of Warrants Activity (Details) |
3 Months Ended |
---|---|
Mar. 31, 2019
$ / shares
shares
| |
Equity [Abstract] | |
Warrants outstanding, beginning balance | 53,130,510,439 |
Warrants outstanding, Increase in warrants during the period as a result of down round provisions | 582,209,844,938 |
Warrants exercised during the period | (755,000,000) |
Warrants outstanding, ending balance | 634,585,355,377 |
Weighted average exercise price, warrants outstanding, beginning balance | $ / shares | $ 0.00172 |
Weighted average exercise price, Increase in warrants during the period as a result of down round provisions | $ / shares | 0.00034 |
Weighted average exercise price, Warrants exercised during the period | $ / shares | $ 0.00014 |
X | ||||||||||
- Definition Weighted average exercise price, warrants outstanding. No definition available.
|
X | ||||||||||
- Definition Weighted average exercise price, Warrants exercised during the period. No definition available.
|
X | ||||||||||
- Definition Weighted average exercise price, Increase in warrants during the period as a result of down round provisions. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|